Cardiometabolic comorbidities in Hispanic/Latino cancer survivors: prevalence and impact on health-related quality of life and supportive care needs

Purpose The aim of this study was to characterize the prevalence of cardiometabolic comorbidities (i.e., diabetes, peripheral vascular disease, myocardial infarction, congestive heart failure, cerebrovascular disease) among Hispanic/Latino cancer survivors and examine the impact of cardiometabolic c...

Full description

Saved in:
Bibliographic Details
Published in:Supportive care in cancer 2023-12, Vol.31 (12), p.711-711, Article 711
Main Authors: Maras, Ashley F., Penedo, Frank J., Ramirez, Amelie G., Worch, Sarah M., Ortiz, Manuel S., Yanez, Betina, Munoz, Edgar, Lad, Thomas, Hollowell, Courtney, Medina, Heidy N., Moreno, Patricia I.
Format: Article
Language:English
Subjects:
Blood circulation disorders
Cancer
Cancer Survivors
Cardiometabolic Risk Factors
Colorectal cancer
Comorbidity
Diabetes
Diabetes Mellitus
Diabetes therapy
Health aspects
Heart attack
Hispanic Americans
Hispanic or Latino
Humans
Medicine
Medicine & Public Health
Nursing
Nursing Research
Oncology
Oncology, Experimental
Pain Medicine
Peripheral Vascular Diseases
Prevalence
Quality of Life
Rehabilitation Medicine
Survivor
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose The aim of this study was to characterize the prevalence of cardiometabolic comorbidities (i.e., diabetes, peripheral vascular disease, myocardial infarction, congestive heart failure, cerebrovascular disease) among Hispanic/Latino cancer survivors and examine the impact of cardiometabolic comorbidities on health-related quality of life (HRQoL), unmet supportive care needs, patient-provider communication self-efficacy, satisfaction with cancer care, and increases in healthy behaviors. Methods Hispanics/Latinos diagnosed with breast, prostate, or colorectal cancer ( N  = 288) were assessed within 15 months of primary treatment completion. Results One-quarter (24.7%) of survivors were diagnosed with diabetes and one-fifth (20.8%) were diagnosed with peripheral vascular disease. Survivors with at least one cardiometabolic comoribidity were older ( t (278) = -.3.622, p  
ISSN:0941-4355
1433-7339
1433-7339
DOI:10.1007/s00520-023-08181-9